Abivax S.A. (ABVX) Estados Financieros e Histórico

Abivax S.A. (ABVX) — Precio $106.99 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Abivax S.A. (ABVX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.

Al precio actual de $106.99, ABVX presenta beneficios negativos (P/E no significativo) y un ROE del -73.87%. La capitalización bursátil es de $7.9B.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$127000$10000$18000$2000$6300000000
Coste de Ventas$14.6M$14.5M$15.4M$28.2M$33.8M$45.5M$50.8M000
Beneficio Bruto-$14.5M-$14.5M-$15.4M-$28.2M-$33.8M-$45.5M-$50.8M000
I+D00000$47.8M$48.3M$103.2M$146.5M$177.8M
Generales y Administrativos$3.6M$3.8M$4.3M$4.9M$5.6M$5.6M$7.5M$28.8M$38.9M$72.9M
Gastos Operativos$3.7M-$347000$3.7M$5.1M$4.2M-$4.1M$14.1M$127.4M$173.0M$246.1M
Beneficio Operativo-$18.2M-$14.2M-$19.1M-$33.3M-$38.0M-$41.4M-$64.8M-$127.4M-$173.0M-$246.1M
EBITDA-$17.9M-$14.0M-$19.2M-$33.2M-$38.0M-$38.6M-$53.3M-$133.2M-$162.7M-$300.7M
Gastos por Intereses$420000$469000$1.6M$2.1M$3.6M$6.9M$13.8M$12.4M$28.5M
Beneficio Antes de Impuestos-$18.0M-$14.1M-$19.8M-$34.9M-$40.1M-$42.5M-$60.7M-$147.7M-$176.2M-$330.3M
Impuestos-$3.5M-$2.7M-$4.0M-$4.3M-$2.6M0000$5.8M
Beneficio Neto-$14.3M-$11.2M-$15.8M-$30.6M-$37.6M-$42.5M-$60.7M-$147.7M-$176.2M-$336.1M
BPA$-1.48$-1.14$-1.56$-2.51$-2.62$-2.75$-3.18$-3.43$-2.80$-4.65
BPA Diluido$-1.47$-1.13$-1.55$-2.51$-2.62$-2.75$-3.18$-3.43$-2.80$-4.65
Acciones en Circulación (Diluidas)$9.7M$9.9M$10.2M$12.2M$14.3M$15.5M$19.1M$43.1M$63.0M$69.5M

Cuenta de Resultados (Trimestral)

Año2024-Q22024-Q42025-Q22025-Q4
Ingresos0000
Beneficio Bruto0000
Beneficio Operativo-$35.3M-$47.2M-$46.5M-$199.6M
EBITDA-$34.6M-$47.6M-$44.6M-$256.1M
Beneficio Neto-$38.8M-$52.4M-$48.4M-$287.7M
BPA$-0.65$-1.50$-1.59$-2.10
BPA Diluido$-0.65$-1.50$-1.59$-2.10

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$7.9M$1.9M$8.0M$9.8M$29.3M$60.7M$26.9M$251.9M$144.2M$516.5M
Inversiones a Corto$15.1M$15.2M$5.0M$6000$6000$60000$9.1M0$13.7M
Cuentas por Cobrar$4.8M$3.6M$7.8M$7.0M$8.0M$8.3M$8.3M$19.1M$15.7M$10.5M
Inventario$52000$1990000$1.2M0$4.0M0000
Activos Corrientes$27.8M$20.9M$21.0M$18.2M$37.7M$75.2M$36.2M$286.0M$170.7M$551.0M
Inmovilizado Material$192000$201000$151000$134000$100000$93000$1.6M$877000$2.7M$2.1M
Fondo de Comercio$32.0M$32.0M$32.0M$32.0M$32.0M$32.7M$18.4M$18.4M$18.4M$18.4M
Activos Intangibles000$85000$98000-$647000$6.6M$6.6M$6.6M$6.6M
Activos Totales$60.6M$53.8M$54.0M$51.7M$71.3M$109.2M$75.5M$327.1M$205.2M$584.1M
Cuentas por Pagar$2.6M$4.2M$6.7M$10.5M$17.4M$18.6M$15.5M$47.2M$43.8M$37.6M
Deuda a Corto$2550000$10.9M$20.7M$12000$10.1M$29.5M$30.9M$42.8M$28.5M
Pasivos Corrientes$3.5M$5.4M$8.5M$12.4M$19.4M$32.3M$51.5M$88.1M$92.8M$63.0M
Deuda a Largo$3160000$10.9M$20.7M$34.0M$40.3M$8.3M$26.6M$52.2M$30.2M
Pasivos Totales$3.9M$5.6M$19.4M$33.1M$53.4M$83.3M$68.4M$131.1M$164.6M$129.1M
Reservas-$35.4M-$46.6M-$62.4M-$93.0M-$37.6M-$81.8M-$143.5M-$282.9M-$438.9M-$738.2M
Patrimonio Neto$56.7M$48.2M$34.7M$18.6M$17.9M$25.9M$7.2M$196.0M$40.6M$455.0M
Deuda Total$3160000$10.9M$20.7M$34.0M$51.7M$39.2M$58.0M$97.4M$45.9M
Deuda Neta-$22.7M-$17.0M-$2.1M$11.0M$4.7M-$9.0M$12.2M-$202.9M-$46.9M-$484.3M
Capital Circulante$24.3M$15.4M$12.5M$5.9M$18.3M$42.9M-$15.3M$197.9M$77.8M$488.0M

Balance (Trimestral)

Año2024-Q22024-Q42025-Q22025-Q4
Caja y Equivalentes$222.3M$144.2M$60.9M$516.5M
Activos Totales$284.5M$205.2M$119.6M$652.1M
Pasivos Totales$158.0M$164.6M$167.9M$140.8M
Patrimonio Neto$126.5M$40.6M-$48.3M$455.0M
Deuda Total$113.4M$97.4M$84.6M$45.9M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$18.2M-$14.2M-$19.1M-$33.3M-$38.0M-$42.5M-$60.7M-$147.7M-$176.2M-$322.8M
Amortizaciones-$35000$93000$71000$80000$66000$302000$485000$707000$1.1M$1.0M
Compensación en Acciones00000$828000-$1.2M$8.2M$20.2M0
Cambio en Capital Circulante$2.5M$5.5M$4.7M$7.0M$9.7M-$668000-$2.0M$21.3M$1.4M$3.5M
Flujo de Caja Operativo-$15.6M-$8.4M-$14.6M-$27.5M-$29.8M-$45.0M-$53.9M-$100.0M-$154.1M-$155.7M
Inversiones (CapEx)-$721000-$979000-$763000-$941000-$898000-$47000-$323000-$265000-$643000-$136396
Adquisiciones000$646000$616000-$2.2M-$2.9M000
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$16.3M-$9.4M-$15.4M-$28.4M-$30.7M-$45.1M-$54.3M-$100.3M-$154.7M-$155.8M

Flujo de Caja (Trimestral)

Año2024-Q22024-Q42025-Q22025-Q4
Flujo de Caja Operativo-$50.4M-$33.3M-$33.3M-$71.3M
Inversiones (CapEx)-$227000-$44000-$19000$8000
Flujo de Caja Libre-$50.6M-$33.3M-$33.4M-$71.3M
Dividendos Pagados0000
Compensación en Acciones$5.7M$4.7M$6.3M-$11.0M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)-92.1%+80.0%-88.9%+3050.0%-100.0%
Crecimiento Beneficio Neto (anual)+21.6%-41.0%-93.6%-22.6%-13.1%-43.1%-143.2%-19.3%-90.7%
Crecimiento BPA (anual)+23.0%-36.8%-60.9%-4.4%-5.0%-15.6%-7.9%+18.4%-66.1%
Cambio en Acciones (anual)+2.0%+2.8%+19.3%+17.5%+8.0%+23.5%+125.6%+46.4%+10.3%
Crecimiento FCF (anual)+42.3%-63.0%-84.9%-8.1%-46.8%-20.3%-84.8%-54.3%-0.7%
Margen Bruto-11431.5%-144970.0%-85327.8%-1409300.0%-53623.8%
Margen Operativo-14359.1%-141500.0%-106155.6%-1664800.0%-60330.2%
Margen EBITDA-14063.8%-139800.0%-106816.7%-1661100.0%-60315.9%
Margen Neto-11266.1%-112230.0%-87905.6%-1531700.0%-59604.8%
Margen FCF-12857.5%-94280.0%-85366.7%-1420700.0%-48763.5%
Tasa Impositiva Efectiva19.6%19.1%20.1%12.2%6.4%-0.0%-0.0%-0.0%-0.0%-1.8%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-1.68$-0.95$-1.51$-2.33$-2.15$-2.92$-2.84$-2.33$-2.45$-2.24
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$9.7M$9.9M$10.2M$12.2M$14.3M$15.5M$19.1M$43.1M$63.0M$69.5M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-73.87%
Rentabilidad sobre capital invertido-44.70%
Rentabilidad sobre activos-57.54%
Margen bruto0.00%
Margen operativo0.00%
Margen neto0.00%

Salud financiera

Deuda / Patrimonio0.10
Ratio corriente8.75
Piotroski F-Score4
Altman Z-Score34.93

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-5.33-6.06-4.64-2.95-2.59-2.65-2.44-2.82-2.52-24.68
P/VC1.341.422.134.855.434.3520.592.1310.9817.54
P/V599.026824.144091.3445076.571542.270.000.000.000.000.00
Margen Bruto-11431.5%-144970.0%-85327.8%-1409300.0%-53623.8%0.0%0.0%0.0%0.0%0.0%
Margen Operativo-14359.1%-141500.0%-106155.6%-1664800.0%-60330.2%0.0%0.0%0.0%0.0%0.0%
Margen Neto-11266.1%-112230.0%-87905.6%-1531700.0%-59604.8%0.0%0.0%0.0%0.0%0.0%

Empresas relacionadas: AXSM · CORT · CYTK · HALO · JAZZ · MDGL · MRUS

Explorar sector: Healthcare · Biotechnology

Más secciones de ABVX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones